ifosfamide has been researched along with Sarcoma, Endometrial Stromal in 5 studies
Sarcoma, Endometrial Stromal: A highly malignant subset of neoplasms arising from the endometrial stroma. Tumors in this group infiltrate the stroma with a wide range of atypia cells and numerous mitoses. They are capable of widespread metastases (NEOPLASM METASTASIS).
Excerpt | Relevance | Reference |
---|---|---|
"To determine the effectiveness and toxicity of ifosfamide chemotherapy in women with metastatic or recurrent endometrial stromal sarcomas unexposed to other chemotherapy." | 9.08 | Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group. ( Blessing, JA; DiSaia, PJ; Park, R; Rosenshein, N; Sutton, G, 1996) |
"To determine the effectiveness and toxicity of ifosfamide chemotherapy in women with metastatic or recurrent endometrial stromal sarcomas unexposed to other chemotherapy." | 5.08 | Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group. ( Blessing, JA; DiSaia, PJ; Park, R; Rosenshein, N; Sutton, G, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Inoue, S | 1 |
Hirai, S | 1 |
Katayama, T | 1 |
Miolo, G | 1 |
Viel, A | 1 |
Canzonieri, V | 1 |
Baresic, T | 1 |
Buonadonna, A | 1 |
Santeufemia, DA | 1 |
Lara, DP | 1 |
Corona, G | 1 |
Ushijima, M | 1 |
Yamakawa, Y | 1 |
Sakabe, E | 1 |
Waki, H | 1 |
Katou, K | 1 |
Sutton, G | 1 |
Blessing, JA | 1 |
Park, R | 1 |
DiSaia, PJ | 1 |
Rosenshein, N | 1 |
Yamawaki, T | 1 |
Shimizu, Y | 1 |
Hasumi, K | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Endometrial Stromal Tumors: an Observational Study[NCT02829437] | 100 participants (Anticipated) | Observational | 2016-10-31 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for ifosfamide and Sarcoma, Endometrial Stromal
Article | Year |
---|---|
Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group.
Topics: Antineoplastic Agents, Alkylating; Drug Administration Schedule; Endometrial Neoplasms; Female; Huma | 1996 |
4 other studies available for ifosfamide and Sarcoma, Endometrial Stromal
Article | Year |
---|---|
[Lung Metastasis from High-grade Uterine Endometrial Stromal Sarcoma;Report of a Case].
Topics: Aged; Endometrial Neoplasms; Female; Heparin; Humans; Ifosfamide; Lung Neoplasms; Sarcoma, Endometri | 2020 |
Association of the germline BRCA2 missense variation Glu2663Lys with high sensitivity to trabectedin-based treatment in soft tissue sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bone Neoplasms; BRCA2 Protein; Dioxol | 2016 |
[A case of recurrent high-grade endometrial stromal sarcoma controlled by a combination of Ifosfamide, adriamycin, and cisplatin].
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endomet | 2010 |
Treatment of stage IV "high-grade" endometrial stromal sarcoma with ifosfamide, adriamycin, and cisplatin.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxoru | 1997 |